Биостатистика, фармакокинетика и клинические исследования.

Домашняя страница
- О сайте
Материалы
- Быстрые команды R Project
- Ссылки
Инструменты
- Рандомизационный список
Блог
Контакты
Профиль
- Войти
- Зарегистрироваться

Tmax

Время достижения максимальной концентрации.

Навигация по записям

Предыдущая запись: биоэквивалентность

Найти:

Свежие записи

Long WS Wide: или про то, как выполнить анализ разницы изменений между группами
Частые вопросы: Регистрация и экспертиза по правилам ЕАЭС
Главные ошибки при формировании базы данных в MS Excel
Тест ClinicalTrialUtilities и ReplicateBE на Raspberry Pi 4
Julia:ReplicateBE – release 0.2.0

Галерея

IMG-20170807-WA0033

20170730 183005

20180128 173717

20180129 140251

Human medicines European public assessment report (EPAR): Siklos, hydroxycarbamide, Date of authorisation: 29/06/2007, Revision: 26, Status: Authorised
Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2024-10-14
Human medicines European public assessment report (EPAR): Apixaban Accord, apixaban, Date of authorisation: 23/07/2020, Revision: 3, Status: Authorised
Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2024-10-14
Human medicines European public assessment report (EPAR): Deferasirox Mylan, deferasirox, Date of authorisation: 26/09/2019, Revision: 10, Status: Authorised
Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2024-10-14
Human medicines European public assessment report (EPAR): Comirnaty, COVID-19 mRNA vaccine,tozinameran,riltozinameran and tozinameran,famtozinameran and tozinameran,raxtozinameran, Date of authorisation: 21/12/2020, Revision: 50, Status: Authorised
Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2024-10-14
Human medicines European public assessment report (EPAR): Kapruvia, difelikefalin, Date of authorisation: 25/04/2022, Revision: 3, Status: Authorised
Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2024-10-14
FDA Roundup: October 11, 2024
Source: FDA - What's New: Drugs RSS Feed Published on 2024-10-11 By FDA
FDA Clinical Investigator Training Course (CITC) 2024 - 12/10/2024
Source: FDA - What's New: Drugs RSS Feed Published on 2024-10-11 By FDA
Newly Added Guidance Documents
Source: FDA - What's New: Drugs RSS Feed Published on 2024-10-11 By FDA
Good Clinical Practice
Source: FDA - What's New: Drugs RSS Feed Published on 2024-10-11 By FDA
Temporary Policies for Compounding Certain Parenteral Drug Products
Source: FDA - What's New: Drugs RSS Feed Published on 2024-10-11 By FDA
Registered Outsourcing Facilities
Source: FDA - What's New: Drugs RSS Feed Published on 2024-10-11 By FDA
Drug Shortages
Source: FDA - What's New: Drugs RSS Feed Published on 2024-10-11 By FDA
FDA Approves New Treatment for Hemophilia A or B
Source: FDA - What's New: Drugs RSS Feed Published on 2024-10-11 By FDA
October 29, 2024: Meeting of the Pharmacy Compounding Advisory Committee - 10/29/2024
Source: FDA - What's New: Drugs RSS Feed Published on 2024-10-11 By FDA
Ways for Consumers to Contact FDA about Human Drugs
Source: FDA - What's New: Drugs RSS Feed Published on 2024-10-11 By FDA

Предыдущие записи

Тема: Scaffold от Danny Cooper.